NYSE · LIFE INSURANCE · SMALL CAP
American National Group Inc. ANG-PD
17 fiscal years on record · USD · FY2025 reported · SEC filings only
12 YEARS OF DIVIDEND GROWTH
Growth
USD 7.5B
Revenue, FY2025 · full 17-year series below
Revenue $B
Net income $B
FY2025 · Revenue 7.5 · Net income 0.5
Compound annual growth
+74.3%
+25.3%
+17.3%
+12.5%
−34.8%
−4.5%
+9.3%
+18.3%
−33.2%
−16.3%
−4.8%
+6.3%
+6.7%
+9.1%
−47.7%
+11.2%
+10.6%
+15.5%
3 yrs
5 yrs
10 yrs
15 yrs
Revenue compounded at +25.3% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
7 cents
of every revenue dollar became profit
Operating margin
Net margin
FY2025 · Operating 5.3% · Net 7.2%
ROE
FY2024 · ROE 24.1%
The 17-year record
17 fiscal years
Every figure from documents filed with the SEC · USD
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 7.5 | 7.5 | 3.4 | 1.4 | 3.7 | 2.4 | 3.5 | 1.5 | 3.9 | 2.2 | 1.5 | 2.2 | 2.6 | 1.7 | 1.2 | 1.3 | 1.2 |
| Operating income $B | 0.4 | 0.4 | 0.5 | 2.4 | 0.7 | 0.8 | 0.3 | · | · | · | · | · | · | · | · | · | · |
| EBITDA $B | 0.6 | 0.4 | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
| Income tax $B | −0.0 | −0.2 | 0.0 | 0.5 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | 0.5 | 0.7 | 0.4 | 1.9 | 0.6 | 0.7 | 0.2 | 0.5 | 0.2 | 0.1 | 0.2 | 0.1 | 0.3 | 0.1 | 0.1 | 0.0 | 0.1 |
| Free cash flow $B | 2.7 | 2.5 | 1.1 | 2.0 | 4.2 | 1.3 | 3.3 | 0.0 | 1.9 | 1.4 | 0.5 | 0.7 | 0.9 | 0.8 | 0.3 | 0.4 | 0.5 |
| EPS, diluted $ | · | · | 2.06 | 20.50 | 5.39 | 6.90 | 2.68 | 5.01 | 1.93 | 0.97 | 2.72 | 1.58 | 3.38 | 0.89 | 1.37 | 0.68 | 1.18 |
| Dividend / sh $ | · | · | · | 0.36 | 0.34 | 0.32 | 0.30 | 0.28 | 0.26 | 0.24 | 0.22 | 0.20 | 0.18 | 0.15 | 0.12 | 0.10 | 0.08 |
| Payout % | 9 | 5 | 191 | 2 | 6 | 4 | 11 | 6 | 13 | 25 | 8 | 12 | 5 | 16 | 8 | 13 | 7 |
| ROE % | · | 24.1 | 14.6 | 44.3 | 8.7 | 12.5 | 7.2 | 17.4 | 6.8 | 3.9 | 10.8 | 7.2 | 16.3 | 3.7 | 7.4 | 5.1 | 9.1 |
| Shares out B | · | · | 0.08 | 0.08 | 0.09 | 0.10 | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 | 0.07 | 0.06 | 0.06 | 0.06 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 48 reconciliationsAUDITED
Reconciled in 17 of 19 fiscal years. 21 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityLife Insurance
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2009